t.dumitru
TL2 Moderator · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 3 October 2024 · last posted 7d
97 posts, newest first. Showing up to 150.
-
Forced degradation studies: designing one that is informative Replied, post #103 · Analytics › Method validation · 21 Jul 2026 · 1 like Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
A structured critique template this community uses — a second dataset Replied, post #42 · Evidence › Study critique · 18 Jul 2026 · 11 likes Coming back to post #40, because the follow-up matters more than the original answer. Confounding: in observational data, is there a third variable that explains the…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #60 · Analytics › Home & field testing · 7 Jul 2026 · 31 likes Worth separating two things that post #56 runs together. Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #58 · Practice › Dosing & titration · 3 Jul 2026 · 12 likes post #57 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #35 · Practice › Administration · 30 Jun 2026 · 5 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #55 · Compounds › Secretagogues & GH axis · 30 Jun 2026 · 23 likes On post #51 — agreed on the reasoning, with one qualification. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #36 · Analytics › Method validation · 28 Jun 2026 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Publication patterns in the BPC-157 literature, examined Replied, post #23 · Compounds › Repair & healing peptides · 28 Jun 2026 · 20 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #37 · Access › Pricing · 26 Jun 2026 · 14 likes On post #33 — agreed on the reasoning, with one qualification. Cost per milligram is the only comparison that survives format differences, but even then it needs care.…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #12 · Analytics › HPLC & UHPLC · 9 Jun 2026 · 0 likes post #11 answers the question as asked. The question underneath it is different. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar…
-
Racemisation and why it is invisible to a mass measurement Replied, post #23 · Analytics › Impurities & related substances · 9 Jun 2026 · 0 likes post #22 is right about the mechanism and I think understates the practical bit. Related substances: compounds chemically related to the target peptide but not the…
-
An 18-month record including the parts that went badly Replied, post #28 · Outcomes › Progress reports · 30 May 2026 · 27 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Purity assay versus content assay: two different numbers Replied, post #2 · Analytics › COA interpretation · 25 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Spreadsheets: an appreciation — what changed since Replied, post #51 · Lounge › Off topic · 24 May 2026 · 25 likes This follows post #48 rather than contradicting it. Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has…
-
Alcohol: what is documented and what is folklore Replied, post #18 · Practice › Interactions · 19 May 2026 · 30 likes post #17 answers the question as asked. The question underneath it is different. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
-
Injection volume, overload, and peak distortion Replied, post #9 · Analytics › HPLC & UHPLC · 16 May 2026 · 29 likes post #8 is right about the mechanism and I think understates the practical bit. Method validation is the demonstration that a method can separate the compound from its…
-
Tracking intake honestly when appetite is absent Replied, post #21 · Nutrition & Training › Protein & intake · 10 May 2026 · 3 likes post #20 answers the question as asked. The question underneath it is different. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per…
-
Request: show the solution author in the topic list — what changed since Replied, post #78 · Meta › Feature requests · 4 May 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #46 · Evidence › Journal club · 2 May 2026 · 22 likes This follows post #43 rather than contradicting it. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question?…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #59 · Sourcing › Vendor reports · 30 Apr 2026 · 12 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Blind submission and why it changes minds — the long version Replied, post #46 · Sourcing › Independent verification · 28 Apr 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #22 · Devices › Syringes & needles · 23 Apr 2026 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #19 · Practice › Reconstitution · 21 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #13 · Practice › Reconstitution · 12 Apr 2026 · 33 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Coming back to: Training through a dose escalation week Replied, post #55 · Nutrition & Training › Resistance training · 18 Mar 2026 · 0 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #77 · Lounge › Introductions · 15 Mar 2026 · 0 likes I read post #75 twice before replying, because I had assumed the opposite. Say hello. No question required. Introduce yourself if you want to give context for why you…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #64 · Compounds › Cagrilintide & amylin analogues · 14 Mar 2026 · 0 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #27 · Compounds › Repair & healing peptides · 10 Mar 2026 · 18 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #45 · Data & Tools › Calculators · 3 Mar 2026 · 17 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Measurement error in a self-reported exposure Replied, post #54 · Evidence › Study critique · 24 Feb 2026 · 3 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #34 · Compounds › Semaglutide · 24 Feb 2026 · 2 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Second pass at: Identical chromatograms across two different lots Replied, post #23 · Sourcing › Red flags · 23 Feb 2026 · 0 likes post #22 answers the question as asked. The question underneath it is different. Exaggerated claims without documentation: every compound has limits. No peptide is…
-
Revisiting: Absolute versus relative contraindications Replied, post #29 · Safety › Contraindications · 21 Feb 2026 · 8 likes I read post #27 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Blinding yourself: practical methods and their limits Replied, post #6 · Research Methods › N-of-1 designs · 19 Feb 2026 · 24 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #13 · Evidence › Journal club · 30 Jan 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #24 · Practice › Storage & stability · 23 Jan 2026 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #36 · Evidence › Trials · 17 Jan 2026 · 1 like post #35 answers the question as asked. The question underneath it is different. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #90 · Practice › Side effects · 13 Jan 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Filter needles: when they help and what they cost you Replied, post #18 · Devices › Syringes & needles · 4 Jan 2026 · 2 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Tracking that stops updating and then resumes — the long version Replied, post #56 · Sourcing › Logistics · 25 Dec 2025 · 7 likes Coming back to post #54, because the follow-up matters more than the original answer. Reshipment after seizure: if a parcel is seized, some suppliers will reship;…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #21 · Compounds › Oral incretins · 28 Nov 2025 · 10 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #76 · Practice › Dosing & titration · 17 Nov 2025 · 3 likes Worth separating two things that post #72 runs together. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #17 · Practice › Side effects · 4 Nov 2025 · 9 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
IGF-1 as a surrogate endpoint and its limitations Replied, post #3 · Compounds › Secretagogues & GH axis · 3 Nov 2025 · 3 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Payment mechanics and the recovery options that do not exist Replied, post #22 · Sourcing › Payments · 19 Oct 2025 · 0 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
Sleep tracking data and its considerable limitations Replied, post #13 · Wellbeing › Sleep · 16 Oct 2025 · 22 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #108 · Practice › Administration · 13 Oct 2025 · 10 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Compounds this community declines to help with, and why Replied, post #46 · Compounds › Other compounds · 2 Oct 2025 · 0 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
About the European Union category Replied, post #6 · Regional › European Union · 25 Sep 2025 · 18 likes On post #2 — agreed on the reasoning, with one qualification. EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #90 · Practice › Side effects · 24 Sep 2025 · 0 likes post #89 is right about the mechanism and I think understates the practical bit. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #9 · Analytics › HPLC & UHPLC · 23 Sep 2025 · 22 likes This follows post #6 rather than contradicting it. On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #81 · Evidence › Study critique · 15 Sep 2025 · 13 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #64 · Evidence › Study critique · 14 Sep 2025 · 1 like What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
Titles that describe the question, not the situation — what changed since Replied, post #4 · Start Here › How to Ask · 9 Sep 2025 · 33 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #7 · Data & Tools › Datasets · 6 Sep 2025 · 3 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
Column chemistry choices for a 40-residue peptide Replied, post #28 · Analytics › HPLC & UHPLC · 4 Sep 2025 · 7 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #50 · Sourcing › Vendor reports · 3 Sep 2025 · 23 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #6 · Practice › Storage & stability · 19 Aug 2025 · 5 likes post #5 is right about the mechanism and I think understates the practical bit. Temperature excursions: if a vial sat at room temperature for a time, the question is…
-
Specification in the result column: why that is a meaningful error Replied, post #30 · Analytics › COA interpretation · 12 Aug 2025 · 5 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
How to research a compound with no human data without deceiving yourself Replied, post #102 · Compounds › Other compounds · 4 Aug 2025 · 1 like Picking up post #99: that is the part I would want checked first. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 2 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #58 · Evidence › Trials · 18 Jul 2025 · 0 likes This follows post #55 rather than contradicting it. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #56 · Compounds › Repair & healing peptides · 2 Jul 2025 · 25 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #147 · Evidence › Journal club · 28 Jun 2025 · 15 likes Picking up post #144: that is the part I would want checked first. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #27 · Nutrition & Training › Protein & intake · 6 Jun 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #18 · Sourcing › Regulatory · 4 Jun 2025 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Individual participant data versus aggregate data Replied, post #31 · Evidence › Meta-analyses · 15 May 2025 · 20 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #26 · Compounds › Oral incretins · 2 May 2025 · 0 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #22 · Sourcing › Independent verification · 18 Apr 2025 · 20 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #51 · Clinical › Comorbidities · 6 Apr 2025 · 0 likes On post #47 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #50 · Compounds › Cagrilintide & amylin analogues · 28 Mar 2025 · 32 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #112 · Pharmacology › Receptor biology · 17 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What a seizure notice actually says Replied, post #41 · Sourcing › Logistics · 11 Mar 2025 · 24 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Certificates issued by the seller versus by a laboratory Replied, post #3 · Analytics › COA interpretation · 11 Mar 2025 · 2 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Follow-up: Requesting a page: what makes a good request Replied, post #7 · Documentation › Wiki requests · 5 Mar 2025 · 4 likes post #6 answers the question as asked. The question underneath it is different. Authority and authorship: if you think a maintained page needs input from someone with…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #125 · Sourcing › Regulatory · 5 Mar 2025 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Consistent declarations and why they matter more than clever ones Replied, post #122 · Sourcing › Logistics · 4 Mar 2025 · 0 likes On post #118 — agreed on the reasoning, with one qualification. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your…
-
A supplier that answers analytical questions with restated claims Replied, post #16 · Sourcing › Red flags · 28 Jan 2025 · 24 likes post #15 answers the question as asked. The question underneath it is different. Safety documentation absent: a supplier that cannot provide information about sterility…
-
Distinguishing a deletion sequence by mass alone Replied, post #20 · Analytics › Mass spectrometry · 26 Jan 2025 · 0 likes Worth separating two things that post #16 runs together. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 13 Jan 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #133 · Compounds › Tirzepatide · 6 Jan 2025 · 13 likes I read post #131 twice before replying, because I had assumed the opposite. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #19 · Compounds › Semaglutide · 19 Dec 2024 · 0 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #71 · Compounds › Tirzepatide · 4 Dec 2024 · 23 likes post #70 answers the question as asked. The question underneath it is different. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #160 · Compounds › Repair & healing peptides · 27 Nov 2024 · 9 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #48 · Wellbeing › Mental health · 24 Oct 2024 · 24 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Transporting a vial for a weekend away Replied, post #5 · Practice › Storage & stability · 24 Oct 2024 · 1 like Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Started this topic · Evidence › Journal club · 13 Oct 2024 · 11 likes Journal club: STEP 4 and what a withdrawal design can prove — one year on Writing it up because I had to work it out twice and would rather nobody else did. Session…
-
Requesting a page: what makes a good request — what changed since Replied, post #67 · Documentation › Wiki requests · 11 Oct 2024 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #18 · Access › Shortages · 9 Oct 2024 · 3 likes Coming back to post #16, because the follow-up matters more than the original answer. Shortage predictions: regulators and suppliers issue shortage alerts before they…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #29 · Compounds › Other compounds · 3 Oct 2024 · 2 likes Picking up post #26: that is the part I would want checked first. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #27 · Clinical › Bloodwork · 13 Sep 2024 · 9 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #19 · Clinical › Special populations · 6 Sep 2024 · 32 likes post #18 answers the question as asked. The question underneath it is different. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning…
-
Correlation in a self-tracked dataset: what it can support Replied, post #84 · Research Methods › Statistics · 23 Aug 2024 · 13 likes Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to…
-
MHRA statements, read directly — the long version Replied, post #2 · Regional › UK & Ireland · 21 Aug 2024 · 31 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #9 · Sourcing › Independent verification · 21 Aug 2024 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
How this community labels and discusses unrefereed work Replied, post #86 · Evidence › Preprints · 15 Jul 2024 · 8 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Assessing a warm arrival: the decision process — one year on Replied, post #70 · Sourcing › Logistics · 31 May 2024 · 23 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…